These are not universally severe, but they signal that BPC157 is not a zeroreaction compound
It raises questions for post-operative vascular surgery and disorders of venous return
GHK-Cu was discussed in FDA compounding-related contexts
In crushed gastrocnemius muscle studies, BPC-157 administered either intraperitoneally or locally as a topical cream improved muscle healing macroscopically (reduced hematoma and edema, prevention of post-injury leg contracture), microscopically, and functionally
By blocking HAI-1, Dihexa allows endogenous HGF to remain active for longer periods and at higher effective concentrations
Treatment regimens typically include more frequent injections initially (e.g., three times weekly for two weeks in non-neurological deficiency